BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18819034)

  • 21. Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?
    Jaźwińska-Tarnawska E; Jęśkowiak I; Waszczuk E; Mulak A; Głowacka K; Hurkacz M; Paradowski L; Zaleska Z; Wiela-Hojeńska A
    Pharmacol Rep; 2015 Apr; 67(2):294-8. PubMed ID: 25712653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients.
    Urcelay E; Mendoza JL; Martín MC; Mas A; Martínez A; Taxonera C; Fernandez-Arquero M; Díaz-Rubio M; de la Concha EG
    Inflamm Bowel Dis; 2006 Jan; 12(1):33-7. PubMed ID: 16374256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.
    de Vries HS; te Morsche RH; van Oijen MG; Nagtegaal ID; Peters WH; de Jong DJ
    PLoS One; 2010 Nov; 5(11):e15011. PubMed ID: 21124790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).
    Englund G; Jacobson A; Rorsman F; Artursson P; Kindmark A; Rönnblom A
    Inflamm Bowel Dis; 2007 Mar; 13(3):291-7. PubMed ID: 17206689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
    Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of MDR1 gene polymorphisms on IBD predisposition and response to glucocorticoids in IBD in a Chinese population.
    Yang QF; Chen BL; Zhang QS; Zhu ZH; Hu B; He Y; Gao X; Wang YM; Hu PJ; Chen MH; Zeng ZR
    J Dig Dis; 2015 Jan; 16(1):22-30. PubMed ID: 25346426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of inflammatory bowel disease with the polymorphisms and haplotypes of fucosyltransferase 3 gene].
    Guo M; Min X; Xia X; Lin X; Jiang L; Jin J; Ding R; Jiang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):849-54. PubMed ID: 26663064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease.
    Mendoza JL; Urcelay E; Lana R; Martín MC; López N; Guijarro LG; Mayol JA; Taxonera C; de la Concha EG; Peña AS; Díaz-Rubio M
    Inflamm Bowel Dis; 2007 May; 13(5):585-90. PubMed ID: 17262810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.
    Chen M; Xue X; Wang F; An Y; Tang D; Xu Y; Wang H; Yuan Z; Gao W; Wei J; Zhang J; Miao Y
    Oncol Rep; 2012 Jan; 27(1):265-9. PubMed ID: 21956451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease.
    Cucchiara S; Latiano A; Palmieri O; Canani RB; D'Incà R; Guariso G; Vieni G; De Venuto D; Riegler G; De'Angelis GL; Guagnozzi D; Bascietto C; Miele E; Valvano MR; Bossa F; Annese V;
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):171-9. PubMed ID: 17255827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease.
    Oostenbrug LE; Dijkstra G; Nolte IM; van Dullemen HM; Oosterom E; Faber KN; de Jong DJ; van der Linde K; te Meerman GJ; van der Steege G; Kleibeuker JH; Jansen PL
    Scand J Gastroenterol; 2006 Oct; 41(10):1174-82. PubMed ID: 16990202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between variants in the ABCB1 (MDR1) gene and corticosteroid dependence in children with Crohn's disease.
    Krupoves A; Mack D; Seidman E; Deslandres C; Amre D
    Inflamm Bowel Dis; 2011 Nov; 17(11):2308-17. PubMed ID: 21987299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease.
    Palmieri O; Latiano A; Salvatori E; Valvano MR; Bossa F; Latiano T; Corritore G; di Mauro L; Andriulli A; Annesec V
    Am J Gastroenterol; 2010 Jul; 105(7):1586-94. PubMed ID: 20125127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between NRAMP1 Polymorphisms and Susceptibility to Ulcerative Colitis/Crohn's Disease: A Meta-Analysis.
    Sun M; Zhang L; Shi S
    Immunol Invest; 2016; 45(3):255-70. PubMed ID: 27019053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.
    Cascorbi I; Flüh C; Remmler C; Haenisch S; Faltraco F; Grumbt M; Peters M; Brenn A; Thal DR; Warzok RW; Vogelgesang S
    Pharmacogenomics; 2013 Apr; 14(5):485-94. PubMed ID: 23556446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y; Miura M; Sunagawa S; Kagaya H; Yasui-Furukori N; Uno T
    Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.